n-dodecyl-b-d-maltoside
Small moleculeexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Jun 30, 2020 (NCT04387461)
Timeline
Indications
Mechanism of action
- Unspecified targetSurfactant
surfactant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07283835 | Phase 2 | Dec 4, 2025 | Fudan University, Lepu Medical Technology (Beijing) Co., Ltd. |
| NCT06567743 | Phase 2 | Sep 16, 2024 | Cold Genesys, Inc. |
| NCT06111235 | Phase 3 | Dec 14, 2023 | Cold Genesys, Inc., University of Texas, San Antonio |
| NCT04452591 | Phase 3 | Oct 27, 2020 | Cold Genesys, Inc. |
| NCT04387461 | Phase 2 | Jun 30, 2020 | Cold Genesys, Inc. |
| NCT06443944 | N/A | — | Cold Genesys, Inc. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cold Genesys, Inc. | For profit | 5 | 5 | 3 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Lepu Medical Technology (Beijing) Co., Ltd. | For profit | 1 | 1 | 1 | 2025 |
| University of Texas, San Antonio | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1